XTX Topco’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-101,509
Closed -$250K – 4407
2026
Q1
$250K Sell
101,509
-39,358
-28% -$132K ﹤0.01% 2650
2025
Q4
$561K Buy
140,867
+68,763
+95% +$304K 0.01% 1489
2025
Q3
$273K Buy
+72,104
New +$245K 0.01% 1580
2024
Q4
– Sell
-43,039
Closed -$53.4K – 2577
2024
Q3
$53.4K Buy
43,039
+25,163
+141% +$31.5K ﹤0.01% 1685
2024
Q2
$29.9K Sell
17,876
-12,609
-41% -$22.5K ﹤0.01% 1571
2024
Q1
$56.7K Sell
30,485
-5,466
-15% -$10.1K 0.01% 1452
2023
Q4
$68.3K Buy
+35,951
New +$53.7K 0.02% 1190
2023
Q2
– Sell
-10,579
Closed -$36.6K – 1602
2023
Q1
$36.6K Buy
+10,579
New +$51.2K 0.01% 1191

Other funds holding NBP

XTX Topco's NBP Position: Q2 2026 in Review

XTX Topco sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 101,509 shares — an estimated $250K sold.

XTX Topco first reported a position in NBP in Q1 2023 and held it in 8 quarters. The position peaked at $561K in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • XTX Topco reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 101,509 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $250K.
  • XTX Topco first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2023 and held it in 8 quarters.
  • XTX Topco's NovaBridge Biosciences American Depositary Shares position peaked at $561K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.